Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD

Clinical trial NCT03803124 · COMPLETED

Trial details

NCT number: NCT03803124
Sponsor: Regional Hospital Holstebro
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Polycystic Kidney, Autosomal Dominant

Start date: 2015-12-01
Primary completion: 2017-12-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.